Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Infectious Diseases

• Publication date

  2013-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/infdis/jit247PMID 23737601PMCID PMC3749004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An overview of anthrax infection including the recently identified form of disease in injection drug users

  2012cited by this paper
• Mycobacterium tuberculosis Infection and Tissue Factor Expression in Macrophages

  2012cited by this paper
• Infection and Inflammation as Risk Factors for Thrombosis and Atherosclerosis

  2012cited by this paper
• Anthrax lethal and edema toxins fail to directly impair human platelet function.

  2012cited by this paper
• Anthrax and the inflammasome.

  2012cited by this paper
• Cytoskeleton as an Emerging Target of Anthrax Toxins

  2012cited by this paper
• The effect of heparin administration in animal models of sepsis: A prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies*

  2011cited by this paper
• Anthrax infection.

  2011cited by this paper
• The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model

  2011cited by this paper
• Secreted Bacillus anthracis proteases target the host fibrinolytic system.

  2011cited by this paper
• Inflammatory Cytokine Response to Bacillus anthracis Peptidoglycan Requires Phagocytosis and Lysosomal Trafficking

  2010cited by this paper
• Pathology of Inhalational Anthrax Animal Models

  2010cited by this paper
• Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock.

  2010cited by this paper
• Activation of plasminogen activator inhibitor implicates protease InhA in the acute-phase response to Bacillus anthracis infection.

  2009cited by this paper
• Guidelines for the diagnosis and management of disseminated intravascular coagulation

  2009cited by this paper
• Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model

  2009cited by this paper
• Anthrax toxins: a weapon to systematically dismantle the host immune defenses.

  2009cited by this paper
• Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions

  2008cited by this paper
• Bacillus anthracis Peptidoglycan Stimulates an Inflammatory Response in Monocytes through the p38 Mitogen-Activated Protein Kinase Pathway

  2008cited by this paper
• Staphylococcal peptidoglycan initiates an inflammatory response and procoagulant activity in human vascular endothelial cells: a comparison with highly purified lipoteichoic acid and TSST-1.

  2008cited by this paper
• Degradation of Circulating von Willebrand Factor and Its Regulator ADAMTS13 Implicates Secreted Bacillus anthracis Metalloproteases in Anthrax Consumptive Coagulopathy*

  2008cited by this paper
• Neutrophil elastase and syndecan shedding contribute to antithrombin depletion in murine anthrax.

  2008cited by this paper
• Anthrax toxin evades Toll‐like receptor recognition, whereas its cell wall components trigger activation via TLR2/6 heterodimers

  2007cited by this paper
• Scalable purification of Bacillus anthracis protective antigen from Escherichia coli.

  2006cited by this paper
• Inhibition of platelet aggregation by anthrax edema toxin.

  2006cited by this paper
• Sepsis and pathophysiology of anthrax in a nonhuman primate model.

  2006cited by this paper
• Systematic Review: A Century of Inhalational Anthrax Cases from 1900 to 2005

  2006cited by this paper
• Pathophysiological Manifestations in Mice Exposed to Anthrax Lethal Toxin

  2005cited by this paper
• Antiplatelet activities of anthrax lethal toxin are associated with suppressed p42/44 and p38 mitogen-activated protein kinase pathways in the platelets.

  2005cited by this paper
• Lethal toxin of Bacillus anthracis inhibits tissue factor expression in vascular cells

  2004cited by this paper
• Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats.

  2004cited by this paper
• Production and purification of Bacillus anthracis protective antigen from Escherichia coli.

  2004cited by this paper
• Production of Biologically Active Bacillus anthracis Edema Factor in Escherichia coli

  2004cited by this paper
• Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice.

  2003cited by this paper
• Pathology and pathogenesis of bioterrorism-related inhalational anthrax.

  2003cited by this paper
• Inhalational anthrax and bioterrorism

  2003cited by this paper
• Bench-to-bedside review: Functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis

  2002influential reference
• Peptidoglycan from Staphylococcus aureus Induces Tissue Factor Expression and Procoagulant Activity in Human Monocytes

  2002cited by this paper
• Cutaneous anthrax associated with microangiopathic hemolytic anemia and coagulopathy in a 7-month-old infant.

  2002cited by this paper
• A cell wall component from pathogenic and non-pathogenic gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of tumour necrosis factor-alpha, nitric oxide production, shock, and multiple organ injury/dysfunction in the rat.

  2001cited by this paper
• Negative and positive ion matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and positive ion nano-electrospray ionization quadrupole ion trap mass spectrometry of peptidoglycan fragments isolated from various Bacillus species.

  2001cited by this paper
• Quantitative Pathology of Inhalational Anthrax I: Quantitative Microscopic Findings

  2001cited by this paper
• Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.

  1993cited by this paper
• Isolation and purification of cell wall polysaccharide of Bacillus anthracis (Δ Sterne)

  1991cited by this paper
• Isolation and purification of cell wall polysaccharide of Bacillus anthracis (delta Sterne).

  1991cited by this paper
• Case records of the Massachusetts General Hospital.

  1990cited by this paper
• Development of mutants of the mosquitocidal bacterium Bacillus thuringiensis subspecies morrisoni (PG-14) toxic to lepidopterous or dipterous insects.

  1990cited by this paper
• Gas chromatographic analysis of amino acids as the N-heptafluorobutyryl isobutyl esters.

  1987cited by this paper
• Microdetermination of Phosphorus

  1979cited by this paper
• THE CHEMISTRY OF THE CELL WALLS OF BACILLUS ANTHRACIS: THE EFFECT OF PENICILLIN.

  1965cited by this paper
• Microdetermination of Phosphorus

  1956cited by this paper
• Observations on the cause of death in experimental anthrax.

  1954cited by this paper
• Determination of Dextran with Anthrone

  1953cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Anthrax Toxins Exacerbate Sepsis-Induced Coagulopathy and Endothelial Dysfunction in a Baboon Model of Anthrax.

  2025cites this paper
• Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3

  2024cites this paper
• Determinants of bacterial survival and proliferation in blood

  2024cites this paper
• Monocyte uptake of polymeric peptidoglycan is bimodal and governed by complement C3 and C4 opsonins

  2024cites this paper
• Peptidoglycan from Bacillus anthracis Inhibits Human Macrophage Efferocytosis in Part by Reducing Cell Surface Expression of MERTK and TIM-3

  2023cites this paper
• Atypical disseminated intravascular coagulopathy during bubonic plague

  2022cites this paper
• Internalization of Polymeric Bacterial Peptidoglycan Occurs through Either Actin or Dynamin Dependent Pathways

  2022cites this paper
• A Review of the Efficacy of FDA-Approved B. anthracis Anti-Toxin Agents When Combined with Antibiotic or Hemodynamic Support in Infection- or Toxin-Challenged Preclinical Models

  2021cites this paper
• Complement C5 inhibition protects against hemolytic anemia and acute kidney injury in anthrax peptidoglycan-induced sepsis in baboons

  2021cites this paper
• Structural Integrity of the Alveolar-Capillary Barrier in Cynomolgus Monkeys Challenged with Fully Virulent and Toxin-Deficient Strains of Bacillus Anthracis.

  2020cites this paper
• C3 Opsonization of Anthrax Bacterium and Peptidoglycan Supports Recognition and Activation of Neutrophils

  2020cites this paper
• Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development

  2020cites this paper
• Hydrocortisone decreases lethality and inflammatory cytokine and nitric oxide production in rats challenged with B. anthracis cell wall peptidoglycan

  2020cites this paper
• Monocyte procoagulant responses to anthrax peptidoglycan are reinforced by proinflammatory cytokine signaling.

  2019cites this paper
• Muramyl dipeptide potentiates a Bacillus anthracis poly‐&ggr;‐d‐glutamic acid capsule surrogate that induces maturation and activation of mouse dendritic cells

  2018cites this paper
• Neither Lys- and DAP-type peptidoglycans stimulate mouse or human innate immune cells via Toll-like receptor 2

  2018cites this paper
• Peptidoglycan induces disseminated intravascular coagulation in baboons through activation of both coagulation pathways.

  2018cites this paper
• Serum Amyloid P and IgG Exhibit Differential Capabilities in the Activation of the Innate Immune System in Response to Bacillus anthracis Peptidoglycan

  2018cites this paper
• Bacillus anthracis Edema Toxin Increases Fractional Free Water and Sodium Reabsorption in an Isolated Perfused Rat Kidney Model

  2017cites this paper
• A systematic review and meta-analysis of preclinical trials testing anti-toxin therapies for B. anthracis infection: A need for more robust study designs and results

  2017cites this paper
• Modulation of innate immunity by enteropathogen motifs

  2016cites this paper
• Nitric oxide production contributes to Bacillus anthracis edema toxin-associated arterial hypotension and lethality: ex vivo and in vivo studies in the rat.

  2016cites this paper
• Discovery of small molecule FcγRIIa Antagonists

  2015cites this paper
• Acquired coagulant factor VIII deficiency induced by Bacillus anthracis lethal toxin in mice

  2015cites this paper
• Molecular determinants for a cardiovascular collapse in anthrax.

  2014cites this paper
• Glycan surface antigens from Bacillus anthracis as vaccine targets: current status and future perspectives

  2014cites this paper
• Purified cell wall from the probiotic bacterium Lactobacillus gasseri activates systemic inflammation and, at higher doses, produces lethality in a rat model

  2014cites this paper
• Confirmed Bacillus anthracis Infection among Persons Who Inject Drugs, Scotland, 2009–2010

  2014cites this paper
• B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

  2013cites this paper
• B. anthracis associated cardiovascular dysfunction and shock: the potential contribution of both non-toxin and toxin components

  2013cites this paper